The role of aldosterone in OSA and OSA-related hypertension
Y Wang, CX Li, YN Lin, LY Zhang, SQ Li… - Frontiers in …, 2022 - frontiersin.org
Obstructive sleep apnea (OSA) is regarded as an independent risk factor for hypertension.
The possible mechanism includes oxidative stress, endothelial injury, sympathetic …
The possible mechanism includes oxidative stress, endothelial injury, sympathetic …
Influence and implications of the renin–angiotensin–aldosterone system in obstructive sleep apnea: An updated systematic review and meta‐analysis
Obstructive sleep apnea is a chronic, sleep‐related breathing disorder, which is an
independent risk factor for cardiovascular disease. The renin–angiotensin–aldosterone …
independent risk factor for cardiovascular disease. The renin–angiotensin–aldosterone …
Characteristics of hypertension in obstructive sleep apnea: an Asian experience
S Hoshide, K Kario, YC Chia, S Siddique… - The Journal of …, 2021 - Wiley Online Library
Obstructive sleep apnea (OSA) is a risk of hypertension and is associated with
cardiovascular disease (CVD) incidence. In Asian countries, the prevalence of OSA is high …
cardiovascular disease (CVD) incidence. In Asian countries, the prevalence of OSA is high …
Prevalence of primary aldosteronism in patients with concomitant hypertension and obstructive sleep apnea, baseline data of a cohort
M Heizhati, X Aierken, L Gan, M Lin, Q Luo… - Hypertension …, 2023 - nature.com
Obstructive sleep apnea (OSA) and primary aldosteronism (PA) often coexist in
hypertension, whereas whether hypertensive patients with OSA should be screened for PA …
hypertension, whereas whether hypertensive patients with OSA should be screened for PA …
Primary aldosteronism and obstructive sleep apnea: A meta-analysis of prevalence and metabolic characteristics
R Zhang, X Cai, W Yang, F Lv, X Han, L Ji - Sleep Medicine, 2024 - Elsevier
Background Primary aldosteronism (PA) and obstructive sleep apnea (OSA) are both
causes for resistant hypertension and contribute to adverse cardiovascular outcome …
causes for resistant hypertension and contribute to adverse cardiovascular outcome …
Primary aldosteronism and obstructive sleep apnea: A single-center cross-sectional study of the Japanese population
Y Nakamura, H Kobayashi, S Tanaka, Y Hatanaka… - Medicine, 2021 - journals.lww.com
A recent report demonstrated that the prevalence of obstructive sleep apnea (OSA) is 67.6%
among Caucasian and Chinese patients with primary aldosteronism (PA). Moreover, the …
among Caucasian and Chinese patients with primary aldosteronism (PA). Moreover, the …
Impact of primary aldosteronism in resistant hypertension
K Stavropoulos, KP Imprialos, D Patoulias… - Current Hypertension …, 2022 - Springer
Abstract Purpose of Review In this narrative review, we aim to summarize the latest data on
the association between primary aldosteronism and resistant hypertension, as well as to …
the association between primary aldosteronism and resistant hypertension, as well as to …
Assessment of screening for nasal obstruction among sleep dentistry outpatients with obstructive sleep apnea
A Sawa, H Suzuki, H Niwa, S Oguchi, T Yagi, Y Iwata… - Dentistry Journal, 2020 - mdpi.com
Oral appliances (OA), a common treatment modality for obstructive sleep apnea (OSA), are
not suitable for patients with nasal obstruction. Rhinomanometry, the gold standard …
not suitable for patients with nasal obstruction. Rhinomanometry, the gold standard …
醛固酮瘤及特发性醛固酮增多症合并阻塞性睡眠呼吸暂停低通气综合征的临床特征分析
左飞杰， 周小花， 任艳， 陈涛， 田浩明 - 四川大学学报(医学版), 2020 - ykxb.scu.edu.cn
醛固酮瘤及特发性醛固酮增多症合并阻塞性睡眠呼吸暂停低通气综合征的临床特征分析* Page
1 醛固酮瘤及特发性醛固酮增多症合并阻塞性睡眠呼吸 暂停低通气综合征的临床特征分析* 左 …
1 醛固酮瘤及特发性醛固酮增多症合并阻塞性睡眠呼吸 暂停低通气综合征的临床特征分析* 左 …
[PDF][PDF] 中国高血压患者原发性醛固酮增多症的前瞻性筛查研究进展
陈歆， 程艾邦， 许建忠， 李燕， 王继光 - 诊断学理论与实践, 2020 - qk.sjtu.edu.cn
中国高血压患者原发性醛固酮增多症的前瞻性筛查研究进展 Page 1 J Diagn Concepts Pract
2020, Vol.19, No.5 !专家论坛! 中国高血压患者原发性醛固酮增多症的 前瞻性筛查研究进展 陈 …
2020, Vol.19, No.5 !专家论坛! 中国高血压患者原发性醛固酮增多症的 前瞻性筛查研究进展 陈 …